Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikita Hanning

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Vaccine|July 17, 2024
Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trialKatie Steenackers, Nikita Hanning, Liesbeth Bruckers, et al.
International Journal of Molecular Sciences|October 13, 2021
Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-ColitisMichelle De Bruyn, Hannah Ceuleers, Nikita Hanning, et al.
Gut|October 7, 2020
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBSEluisa Perna, Javier Aguilera-Lizarraga, Morgane V Florens, et al.
Pharmaceutics|June 2, 2021
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in RatsNikita Hanning, Michelle De Bruyn, Hannah Ceuleers, et al.
Frontiers in Pharmacology|June 20, 2022
The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal InsultHannah Ceuleers, Nikita Hanning, Michelle De Bruyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2026
Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged ≥50 years: a phase 3, randomized, non-inferiority trialMarc Bonten, Brandon Essink, Nikita Hanning, et al.
British Journal of Pharmacology|June 19, 2018
Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndromeHannah Ceuleers, Nikita Hanning, Jelena Heirbaut, et al.
Nature Microbiology|April 28, 2022
Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndromeAdam L Edwinson, Lu Yang, Stephanie Peters, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Vaccine|July 17, 2024
Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trialKatie Steenackers, Nikita Hanning, Liesbeth Bruckers, et al.
International Journal of Molecular Sciences|October 13, 2021
Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-ColitisMichelle De Bruyn, Hannah Ceuleers, Nikita Hanning, et al.
Gut|October 7, 2020
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBSEluisa Perna, Javier Aguilera-Lizarraga, Morgane V Florens, et al.
Pharmaceutics|June 2, 2021
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in RatsNikita Hanning, Michelle De Bruyn, Hannah Ceuleers, et al.
Frontiers in Pharmacology|June 20, 2022
The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal InsultHannah Ceuleers, Nikita Hanning, Michelle De Bruyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2026
Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged ≥50 years: a phase 3, randomized, non-inferiority trialMarc Bonten, Brandon Essink, Nikita Hanning, et al.
British Journal of Pharmacology|June 19, 2018
Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndromeHannah Ceuleers, Nikita Hanning, Jelena Heirbaut, et al.
Nature Microbiology|April 28, 2022
Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndromeAdam L Edwinson, Lu Yang, Stephanie Peters, et al.
Pageof 2